UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 2, pp. 153 - 163
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Back Pain - chemically induced | Phenylthiohydantoin - adverse effects | Dyspnea - chemically induced | Myocardial Infarction - chemically induced | Anilides - therapeutic use | Nausea - chemically induced | Phenylthiohydantoin - therapeutic use | Anilides - adverse effects | Humans | Middle Aged | Male | Fatigue - chemically induced | Patient Dropouts | Arthralgia - chemically induced | Fractures, Spontaneous - chemically induced | Hypertension - chemically induced | Aged, 80 and over | Hydronephrosis - chemically induced | Double-Blind Method | Anemia - chemically induced | Prostatic Neoplasms, Castration-Resistant - drug therapy | Disease Progression | Phenylthiohydantoin - analogs & derivatives | Constipation - chemically induced | Disease-Free Survival | Tosyl Compounds - adverse effects | Tosyl Compounds - therapeutic use | Aged | Nitriles - adverse effects | Heart Failure - chemically induced | Hot Flashes - chemically induced | Nitriles - therapeutic use | Care and treatment | Cancer patients | Oncology, Experimental | Clinical trials | Metastasis | Research | Prostate cancer | Cancer | Index Medicus
Journal Article
European urology, ISSN 0302-2838, 2014, Volume 67, Issue 5, pp. 825 - 836
Urology | Prostate cancer | Androgen deprivation therapy | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Gynecomastia - chemically induced | Humans | Male | Metabolic Diseases - chemically induced | Muscle Proteins - drug effects | Bone Diseases, Metabolic - chemically induced | Antineoplastic Agents, Hormonal - adverse effects | Body Composition - drug effects | Antineoplastic Agents, Hormonal - therapeutic use | Androgen Antagonists - therapeutic use | Cardiovascular Diseases - chemically induced | Quality of Life - psychology | Androgen Antagonists - adverse effects | Hot Flashes - chemically induced | Prostatic Neoplasms - drug therapy | Practice Guidelines as Topic | Medical policy | Physiological aspects | Medical colleges | Complications and side effects | Index Medicus
Journal Article
The journal of clinical endocrinology and metabolism, ISSN 0021-972X, 10/2016, Volume 101, Issue 10, pp. 3847 - 3855
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Estradiol - blood | Estradiol - metabolism | Sleep Wake Disorders - chemically induced | Humans | Middle Aged | Gonadotropin-Releasing Hormone - pharmacology | Hot Flashes - metabolism | Healthy Volunteers | Fertility Agents, Female - pharmacology | Young Adult | Sleep Wake Disorders - metabolism | Depression - metabolism | Menopause - metabolism | Leuprolide - administration & dosage | Depression - chemically induced | Adolescent | Adult | Fertility Agents, Female - administration & dosage | Gonadotropin-Releasing Hormone - agonists | Hot Flashes - chemically induced | Leuprolide - pharmacology | Index Medicus | Abridged Index Medicus | Original
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 01/2017, Volume 2017, Issue 1, pp. CD004143 - CD004143
Estrogen Replacement Therapy | Cardiovascular Diseases | Estrogens | Menopause | PREVENTION AND TREATMENT OF LONG TERM PROBLEMS | CLIMACTERIC/MENOPAUSE | Cause of Death | Neoplasms | Randomized Controlled Trials as Topic | Gynaecology | Venous Thromboembolism | Hot Flashes | Postmenopause | Perimenopause | Progesterone | Medicine General & Introductory Medical Sciences | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hot Flashes - drug therapy | Humans | Middle Aged | Neoplasms - mortality | Estrogens - adverse effects | Progesterone - adverse effects | Estrogen Replacement Therapy - adverse effects | Estrogens - therapeutic use | Progesterone - therapeutic use | Estrogen Replacement Therapy - methods | Neoplasms - chemically induced | Venous Thromboembolism - chemically induced | Aged, 80 and over | Cardiovascular Diseases - mortality | Adult | Female | Aged | Cardiovascular Diseases - chemically induced | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 04/2017, Volume 35, Issue 10, pp. 1041 - 1048
Life Sciences & Biomedicine | Oncology | Science & Technology | Dyspnea - chemically induced | Triazoles - adverse effects | Myalgia - chemically induced | Humans | Middle Aged | Receptors, Estrogen - analysis | Arthralgia - chemically induced | Breast Neoplasms - therapy | Antineoplastic Agents, Hormonal - adverse effects | Receptors, Progesterone - analysis | Antineoplastic Agents, Hormonal - therapeutic use | Depression - chemically induced | Hypertension - chemically induced | Mastectomy | Postmenopause | Female | Chemotherapy, Adjuvant | Triazoles - therapeutic use | Anastrozole | Survival Rate | Lymphatic Metastasis | Disease-Free Survival | Breast Neoplasms - pathology | Aged | Receptor, ErbB-2 - analysis | Neoplasm Staging | Nitriles - adverse effects | Hot Flashes - chemically induced | Letrozole | Nitriles - therapeutic use | Index Medicus
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1465-1858, 10/2016, Volume 2016, Issue 11, pp. CD008536 - CD008536
Estrogen Replacement Therapy | Stroke | Sweating | Menopause | Neoplasm Recurrence, Local | Estrogen Receptor Modulators | PREVENTION AND TREATMENT OF LONG TERM PROBLEMS | Breast Neoplasms | CLIMACTERIC/MENOPAUSE | Randomized Controlled Trials as Topic | Gynaecology | Dyspareunia | Uterine Hemorrhage | Hot Flashes | Postmenopause | Norpregnenes | Medicine General & Introductory Medical Sciences | Hot Flashes - drug therapy | Dyspareunia - drug therapy | Postmenopause - drug effects | Norpregnenes - adverse effects | Humans | Middle Aged | Estrogen Replacement Therapy - adverse effects | Breast Neoplasms - prevention & control | Sweating - drug effects | Estrogen Replacement Therapy - methods | Estrogen Receptor Modulators - therapeutic use | Stroke - chemically induced | Neoplasm Recurrence, Local - chemically induced | Female | Aged | Breast Neoplasms - chemically induced | Norpregnenes - therapeutic use | Estrogen Receptor Modulators - adverse effects | Uterine Hemorrhage - chemically induced | Index Medicus
Journal Article